[SkyPeople Fruit Juice, Inc. 16F, National Bank Tower, No. 2 Gaoxin 1st Road, Xi’an, China 710075 Via EDGAR Division of Corporation Finance 100 F Street, N.E. Attention: Re: Mr. Ethan Horowitz, Branch Chief Ms. Shannon Buskirk, Staff Member SkyPeople Fruit Juice, Inc. Form 8-K filed on December 30, 2011 (File No. 001-34502) Dear Mr. Horowitz and Ms. Buskirk: The Company]
[CHINA SUNERGY ANNOUNCES APPOINTMENT OF CHIEF FINANCIAL OFFICER NANJING, China, January 12, 2012, China Sunergy Co., Ltd. (NASDAQ: CSUN) (“China Sunergy” or the “Company”), a specialized solar cell and module manufacturer, announced today that Mr. Chen has been the acting CFO of the Company since November 2010. From 2003 to October 2010, Mr. Chen worked in China Electric Equipment Group]
[BDO Tel: +852 2218 8288 Fax: +852 2815 2239 www.bdo.com.hk th 25 111 Connaught Road Central Hong Kong 100 F Street N.E. January 13, 2012 Our ref: 074238/ah1211/1301 Dear Sirs: RE: SKYPEOPLE FRUIT JUICE, INC. We have been furnished with a copy of the response to Item 4.01 of the Amendment to Form 8-K for the event that occurred on] [FORM 8-K/A (Amendment No. 1 to Form 8-K) CURRENT REPORT Date of Report (Date of earliest event reported): December 23, 2011 SkyPeople Fruit Juice, Inc. Florida 001-34502 98-0222013 (State or other jurisdiction of incorporation) (IRS Employer Identification No.) 16F, National Development Bank Tower, No. 2, Gaoxin 1st Road, Xi’an, China 710075 (Zip code) 86-29-88377216]
[Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers’ Compensatory Arrangements of Certain Officers (b)(c) Wen Tong, the Chief Financial Officer of Andatee China Marine Fuel Services Corporation (the “Company”), tendered his resignation as the Company’s CFO effective January 12, 2012. Wen Tong’s departure was not due to any disagreement with the Company, but]
[Sinovac Announces Resignation of Chup Hung Mok from Board of Directors Press Release: Sinovac Biotech Ltd. – Wed, Jan 4, 2012 8:00 AM EST BEIJING , Jan. 4, 2012 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA - News), a leading provider of vaccines in China , today announced the resignation of Ms. Chup Hung Mok from its Board of Directors] [SINOVAC BIOTECH LTD. Weidong Yin Chairman and Chief Executive Officer]
[BDO Tel: +852 2218 8288 Fax: +852 2815 2239 www.bdo.com.hk th 25 111 Connaught Road Central Hong Kong 100 F Street N.E. January 13, 2012 Our ref: 074238/ah1211/1301 Dear Sirs: RE: SKYPEOPLE FRUIT JUICE, INC. We have been furnished with a copy of the response to Item 4.01 of the Amendment to Form 8-K for the event that occurred on] [FORM 8-K/A (Amendment No. 1 to Form 8-K) CURRENT REPORT Date of Report (Date of earliest event reported): December 23, 2011 SkyPeople Fruit Juice, Inc. Florida 001-34502 98-0222013 (State or other jurisdiction of incorporation) (IRS Employer Identification No.) 16F, National Development Bank Tower, No. 2, Gaoxin 1st Road, Xi’an, China 710075 (Zip code) 86-29-88377216]
[Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers’ Compensatory Arrangements of Certain Officers (b)(c) Wen Tong, the Chief Financial Officer of Andatee China Marine Fuel Services Corporation (the “Company”), tendered his resignation as the Company’s CFO effective January 12, 2012. Wen Tong’s departure was not due to any disagreement with the Company, but]
[Sinovac Announces Resignation of Chup Hung Mok from Board of Directors Press Release: Sinovac Biotech Ltd. – Wed, Jan 4, 2012 8:00 AM EST BEIJING , Jan. 4, 2012 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA - News), a leading provider of vaccines in China , today announced the resignation of Ms. Chup Hung Mok from its Board of Directors] [SINOVAC BIOTECH LTD. Weidong Yin Chairman and Chief Executive Officer]
[*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to]
